The Scientist

» clinical trials and disease/medicine

Most Recent

image: Clinical Silence

Clinical Silence

By | October 10, 2013

A study has shown that less than half of the outcomes of some clinical trials are publicly available.

0 Comments

image: Progress for First Malaria Vaccine

Progress for First Malaria Vaccine

By | October 8, 2013

Following successful clinical trials, GlaxoSmithKline says it will submit its malaria vaccine for European regulatory approval.

0 Comments

image: Book Excerpt from <em>Evolution and Medicine</em>

Book Excerpt from Evolution and Medicine

By | October 1, 2013

In Chapter 11, “Man-made diseases,” author Robert Perlman describes how socioeconomic health disparities arise in hierarchical societies.

0 Comments

image: Contributors

Contributors

By | October 1, 2013

Meet some of the people featured in the October 2013 issue of The Scientist.

0 Comments

image: Get a Whiff of This

Get a Whiff of This

By | October 1, 2013

An issue devoted to the latest research on how smells lead to actions

2 Comments

image: The Leprosy Bacillus, circa 1873

The Leprosy Bacillus, circa 1873

By | October 1, 2013

A scientist’s desperate attempts to prove that Mycobacterium leprae causes leprosy landed him on trial, but his insights into the disease’s pathology were eventually vindicated.

0 Comments

image: Three-Way Parenthood

Three-Way Parenthood

By , , and | October 1, 2013

Avoiding the transmission of mitochondrial disease takes a trio, but raises a host of logistical issues.

2 Comments

image: Smell and the Degenerating Brain

Smell and the Degenerating Brain

By | October 1, 2013

An impaired sense of smell is one of the earliest symptoms of Alzheimer’s, Parkinson’s, and some other neurodegenerative diseases. Could it be a useful diagnostic tool?

7 Comments

image: Different Cancers, Same Mutations

Different Cancers, Same Mutations

By | September 26, 2013

Scientists document common genetic alterations in cancers of different origins.

4 Comments

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS